Literature DB >> 4373194

Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis.

B L Riggs, J Jowsey, P J Kelly, D L Hoffman, C D Arnaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4373194     DOI： 10.1016/s0300-595x(73)80046-5

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN： 0300-595X


× No keyword cloud information.
  8 in total

1.  Bone and ageing.

Authors:  J Dequeker
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

2.  Endogenous oestrogen and bone loss following oophorectomy.

Authors:  R Lindsay; D M Hart; A Sweeney; J R Coutts; A Clarke
Journal:  Calcif Tissue Res       Date:  1977-05

3.  Fluoride treatment in corticosteroid induced osteoporosis.

Authors:  F Rejou; R Dumas; C Belon; P J Meunier; C Edouard
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

4.  Effects of oral supplementation with stable strontium.

Authors:  S C Skoryna
Journal:  Can Med Assoc J       Date:  1981-10-01       Impact factor: 8.262

5.  Treatment of osteoporosis.

Authors: 
Journal:  Br Med J       Date:  1978-05-20

6.  The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.

Authors:  A Caniggia; R Nuti; F Loré; A Vattimo
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 7.  Treatment of postmenopausal osteoporosis.

Authors:  B E Nordin
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

8.  Inhibitory effect of Astragalus Membranaceus on osteoporosis in SAMP6 mice by regulating vitaminD/FGF23/Klotho signaling pathway.

Authors:  Yihui Chai; Xiang Pu; Yongzhen Wu; Xingzhong Tian; Qian Li; Fanyong Zeng; Jing Wang; Jie Gao; Huaqian Gong; Yunzhi Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.